Doctor profile · Federal record
Dr. PAUL COFFEEN, MD
Clinical Cardiac Electrophysiology Physician (CMS: CARDIAC ELECTROPHYSIOLOGY) · Cardiovascular Disease Physician · AUSTIN, TX
- NPI 1699775627
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3801 N LAMAR BLVD, STE. 300
AUSTIN, TX 787564080
(512) 206-3600
fax (512) 454-2581 - Mailing address
-
7800 SHOAL CREEK BLVD STE 205N, AUSTIN HEART PLLC
AUSTIN, TX 787571016
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- January 25, 2022
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RC0001X — NUCC code
- State license (1)
- Texas #K3698
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699775627. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,788
Distinct HCPCS
10
Medicare allowed
$617,999
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 1,683 | 595 | $23 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,385 | 969 | $14 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 1,177 | 425 | $29 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 988 | 710 | $124 | |
93295 |
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 521 | 186 | $36 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 499 | 73 | $26 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 497 | 72 | $38 | |
93280 |
Programming of dual lead pacemaker system | 377 | 291 | $76 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 213 | 206 | $88 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 186 | 186 | $160 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 126. This provider delivers 70× the peer median.Open Payments
Industry payments received
All-time total
$3,317
Transactions
95
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 49 | $1,179.60 | |
| Biosense Webster, Inc. | 18 | $1,006.11 | |
| ATRICURE, INC. | 4 | $559.40 | |
| PFIZER INC. | 9 | $145.94 | |
| Medtronic, Inc. | 3 | $134.75 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $75.46 | |
| CARDIVA MEDICAL, INC. | 3 | $71.86 | |
| SANOFI-AVENTIS U.S. LLC | 2 | $51.28 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $30.64 | |
| Janssen Pharmaceuticals, Inc | 1 | $30.48 | |
| iRhythm Technologies, Inc. | 1 | $16.30 | |
| SCPHARMACEUTICALS INC. | 1 | $14.81 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,441
Patients
634
Total drug cost
$1,328,328
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 650 | 149 | $644,222 |
| Xarelto (Rivaroxaban) | Brand | 407 | 99 | $450,490 |
| Flecainide Acetate | Generic | 238 | 73 | $12,984 |
| Metoprolol Succinate | Generic | 229 | 73 | $3,130 |
| Multaq (Dronedarone Hcl) | Brand | 131 | 33 | $165,384 |
| Amiodarone Hcl | Generic | 115 | 46 | $4,692 |
| Metoprolol Tartrate | Generic | 115 | 35 | $787 |
| Sotalol (Sotalol Hcl) | Brand | 112 | 34 | $1,668 |
| Propafenone Hcl | Generic | 110 | 29 | $6,391 |
| Digoxin | Generic | 106 | 27 | $2,665 |